Protagonist Reports Final Results From Rusfertide Phase 2 REVIVE Study Showing Durable Hematocrit Control at the ASH 2024 Annual Meeting

December 9, 2024 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced details from a poster presentation with final data from the rusfertide Phase 2 REVIVE study. Rusfertide, a mimetic of the natural hormone hepcidin, has potential therapeutic value in the treatment of polycythemia vera (PV) and other disease indications. The data were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place...

Read more

Alliant Health Solutions Announces Promotion of Dr. Natasha Avery to Chief Operating Officer

December 9, 2024 2:00 PM

ATLANTA, GA / ACCESSWIRE / December 9, 2024 / Alliant Health Solutions is pleased to announce the promotion of Dr. Natasha Avery to Chief Operating Officer (COO), effective immediately. In her new role, Dr. Avery will continue to provide leadership and strategic direction for Alliant's operations, focusing on operational excellence, contract implementation, and the achievement of key performance metrics.Dr. Avery has been a senior leader for...

Read more

Spero Clinic Introduces Innovative Noninvasive Approach to Chronic Pain Management

December 9, 2024 1:00 PM

The Spero Clinic, located in Fayetteville, Arkansas, has unveiled a groundbreaking approach to addressing chronic pain conditions through natural, non-invasive methods. Renowned for treating complex and challenging conditions such as Fibromyalgia, Ehlers-Danlos Syndrome (EDS), Complex Regional Pain Syndrome (CRPS), and Long Covid, the clinic's unique treatment philosophy is transforming lives by focusing on individualized care and innovative...

Read more

Savista’s Chief Strategy Officer Shares Predictions for the Future of Healthcare in 2025

December 9, 2024 11:00 AM

ALPHARETTA, GA / ACCESSWIRE / December 9, 2024 / As the new year approaches, Savista, a leading healthcare revenue cycle management services company, reflects on the state of the healthcare industry today and shares predictions for the future of healthcare in 2025 and beyond.The healthcare industry has undergone dynamic shifts in recent years-with 2024 experiencing labor shortages, pressured margins, a shift toward outsourcing, increased...

Read more

UNOS and Donate Life America Invite You to Honor Donors

December 9, 2024 10:45 AM

The United Network for Organ Sharing (UNOS) and Donate Life America (DLA) invite the public to join the National Tree of Life virtual event to honor and remember this year's organ, eye and tissue donors and their families. Join the United Network for Organ Sharing and Donate Life America for the 5th annual national Tree of Life virtual event live streamed on Donate Life America's Facebook page on December 16 at 6:30 p.m. EST.The National Tree...

Read more

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia

December 9, 2024 10:10 AM

Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Theramex the exclusive commercialization rights to ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures, for Mexico,...

Read more

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

December 9, 2024 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that the data from the recently conducted analysis of the prespecified subgroup of adult patients with breast cancer from the Phase 3 OnTarget trial, which indicate that crofelemer achieved significant results in this subgroup, will be the subject of a poster presentation on December 11, 2024 during the 12:30 - 2:00 p.m. CST Poster Session 1 at...

Read more

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

December 9, 2024 9:10 AM

KELOWNA, BC / ACCESSWIRE / December 9, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the engagement of a contract research organization ("CRO") to design and execute a human pilot study evaluating DehydraTECH-liraglutide against Saxenda® injectable liraglutide.As reported on November 20th in Lexaria's 12-week rodent study with...

Read more

Theralase(R) Launches Three New Clinical Study Sites in USA

December 9, 2024 8:05 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has launched three new US-based Clinical Study Sites ("CSSs") for its...

Read more

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

December 9, 2024 7:30 AM

Fibromyalgia, the chronic pain condition that plagues approximately ten million Americans is in need of new drug treatment options. The existing approved drugs on the market often aren't enough. Unfortunately, many patients, at the direction of their doctors, end up taking opioids as a last resort to manage fibromyalgia. Click here for a 6-minute video of Seth Lederman, MD, reviewing the status of TNX 102-SL for fibromyalgiaOpioids come with...

Read more

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

December 9, 2024 7:30 AM

FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed an orally active protease inhibitor with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2).There are still unmet medical needs...

Read more

How Robot-assisted Surgical Microscope are Enhancing Surgical Interventions? FMI Predicts the Market to Surpass USD 858.0 Million by 2033

December 9, 2024 6:30 AM

The global market for robot-assisted surgical microscopes is projected to achieve a valuation of USD 410.6 million in 2023 and is expected to more than double, reaching USD 858.0 million by 2033, reflecting a CAGR of 7.6% over the forecast period. This growth is fueled by rapid technological advancements in robotic systems, increasing preference for minimally invasive surgical procedures, and the potential for improved patient...

Read more

Bioz Stars Awards 2024: Recognizing the World's Top Suppliers in Scientific Innovation

December 9, 2024 4:00 AM

Bioz, Inc, a leader in AI-powered solutions for scientific research, is proud to announce the winners of the prestigious Bioz Stars Awards 2024, honoring the most innovative suppliers of scientific products, including reagents, kits, instruments, and tools. This year, Bioz recognizes industry leaders who have significantly contributed to advancing scientific discovery through high-quality, trusted products that researchers around the world rely...

Read more

CeraVx B.V. Emerges from Stealth Acquires Micro Needle Technology from MLT Appoints Management and Supervisory Board

December 9, 2024 4:00 AM

CeraVx B.V., a global biotechnology company focused on developing and commercialising a proprietary drug delivery platform, today announced its emergence from stealth mode following a successful bid to acquire key microneedle technology assets from MyLife Technologies B.V. (MLT) and the appointment of its management team and members of the supervisory board.CeraMaps, the company's drug delivery platform, is based on ceramic microneedle array...

Read more

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment

December 9, 2024 3:05 AM

VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, has achieved key milestones in the development of BNT23001, its proprietary sublingual thin-film (OFD) formulation of Cladribine for the treatment of Multiple Sclerosis (MS). These achievements in 2024 lay the groundwork for clinical trials and...

Read more

Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed

December 9, 2024 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical company developing innovative therapies for blood diseases, is pleased to announce the successful completion of the Site Initiation Visit at the first clinical site for its Phase I clinical trial of HG-CT-1 (also known as HEMO-CAR-T). The Phase I clinical trial is designed as a dose escalation study to assess the safety of HG-CT-1 in adult patients with relapsed/refractory (R/R)...

Read more

Global Absorbable Tissue Spacer Market Set to Experience Remarkable Growth, Projected to Surpass USD 303.8 Million by 2032 amid Rising Prostate Cancer Incidence | FMI

December 9, 2024 1:20 AM

The global absorbable tissue spacer market is on a strong growth trajectory, with projections forecasting a significant surge to surpass USD 303.8 million by 2032. This growth is driven by a robust Compound Annual Growth Rate (CAGR) of approximately 10% during the forecast period from 2022 to 2032.A key factor contributing to this growth is the rising prevalence of prostate cancer, particularly among the aging male population. Prostate cancer is...

Read more

Fred Says Foundation Announces Its 2024 Gifts for World AIDS Day

December 7, 2024 12:00 PM

CHICAGO, IL / ACCESSWIRE / December 7, 2024 / As it has done for more than a decade, on December 1st, World AIDS Day, the Fred Says Foundation announced its 2024 giving to youth-serving organizations in the United States and around the world.Founded in 2013 by Dr. Robert Garofalo and his dog, Fred, Fred Says is a non-profit charity supporting U.S. and international organizations that care for or provide services to LGBTQ young people and youth...

Read more

Dr. Airica Steed Honored as a Fellow in the American Academy of Nursing

December 6, 2024 5:00 PM

CLEVELAND, OH / ACCESSWIRE / December 6, 2024 / Dr. Airica Steed, a visionary leader and relentless advocate for health equity, recently celebrated a significant milestone in her already illustrious career. She was inducted as a Fellow in the American Academy of Nursing (AAN), the highest honor and distinction in the nursing profession. This prestigious recognition is not only a testament to her stellar contributions to healthcare but also a...

Read more

Formula Wellness Expands into Virginia Through Strategic Partnership with New Medical Spa

December 6, 2024 1:45 PM

Formula Wellness, an industry leader in customized wellness and beauty treatments, has announced a strategic alliance with New Medical Spa, a leading provider of cutting-edge medical aesthetics in Short Pump, Virginia. With this partnership, Formula Wellness enters the Virginia market for the first time, demonstrating its dedication to providing state-of-the-art medical and aesthetic treatments nationwide.About the PartnershipNew Medical Spa was...

Read more